Rankings
▼
Calendar
RLAY Q1 2023 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$226,000
-46.1% YoY
Gross Profit
-$83M
-36549.1% margin
Operating Income
-$101M
-44768.6% margin
Net Income
-$94M
-41698.7% margin
EPS (Diluted)
$-0.72
QoQ Revenue Growth
-10.7%
Cash Flow
Operating Cash Flow
-$67M
Free Cash Flow
-$69M
Stock-Based Comp.
$22M
Balance Sheet
Total Assets
$1.0B
Total Liabilities
$154M
Stockholders' Equity
$883M
Cash & Equivalents
$161M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$226,000
$419,000
-46.1%
Gross Profit
-$83M
-$51M
-61.2%
Operating Income
-$101M
-$63M
-61.3%
Net Income
-$94M
-$62M
-51.9%
← FY 2023
All Quarters
Q2 2023 →